Early recovery of microvascular perfusion induced by t-PA in combination with abciximab or eptifibatide during postischemic reperfusion

被引：7

作者：

Bertuglia S. ^{[1
]}

Giusti A. ^{[1
]}

机构：

[1] CNR Institute of Clinical Physiology, School of Medicine, University of Pisa

来源：

BMC Cardiovascular Disorders | / 2卷 / 1期

关键词：

Platelet Aggregation; Abciximab; Mean Arterial Blood Pressure; Leukocyte Adhesion; Eptifibatide;

D O I：

10.1186/1471-2261-2-10

中图分类号：

学科分类号：

摘要：

Background: GPIIb/IIIa inhibitors abciximab and eptifibatide have been shown to inhibit platelet aggregation in ischemic heart disease. Our aim was to test the efficacy of abiciximab (Reo Pro) or eptifibatide (Integrilin) alone or in combination with plasminogen activator (t-PA) in an experimental model of ischemia reperfusion (I/R) in hamster cheek pouch microcirculation visualized by fluorescence microscopy. Hamsters were treated with saline, or abiciximab or eptifibatide or these drugs combined with t-PA infused intravenously 10 minutes before ischemia and through reperfusion. We measured the microvessel diameter changes, the arteriolar red blood cell (RBC) velocity, the increase in permeability, the perfused capillary length (PCL), and the platelet and leukocyte adhesion on microvessels. Results: I/R elicited large increases in the platelet and leukocyte adhesion and a decrease in microvascular perfusion. These responses were significantly attenuated by abiciximab or eptifibatide (PCL:70 and 65% at 5-10 mins of reperfusion and 85 and 87% at 30 mins of reperfusion, respectively, p < 0.001) while t-PA combined with abiciximab or eptifibatide, was more effective and microvascular perfusion recovered immediately after postischemic reperfusion. Conclusions: Platelets are crucial in I/R injury, as shown by the treatment with abicixmab or eptifibatide, which decreased platelet aggregation in microvessels, and also decreased leukocyte adhesion in venules. Arterial vasoconstriction, decreased arterial RBC velocity and alterations in the endothelial barrier with increased permeability delayed the complete restoration of blood flow, while t-PA combined with inhibition of platelet aggregation speeded up the capillary perfusion after reperfusion. © 2002 Bertuglia and Giusti; licensee BioMed Central Ltd.

引用

页数：13

共 31 条

[1]

Golino A., Maroko P.R., Carew T.E., Efficacy of platelet depletion in counteracting the detrimental effect of acute hypercolesterolemia on infarct size and the no-reflow phenomenon in rabbits undergoing coronary artery occlusion-reperfusion, Circulation, 76, (1987)

[2]

Massberg S., Enders G., de Melo-Matos F.C., Tomic L.I.D., Leiderer R., Eisenmenger S., Messmer K., Krombach F., Fibrinogen deposition at the postischemic vessel wall promotes platelet adhesion during ischemia reperfusion in vivo, Blood, 94, (1999)

[3]

Salter W., Krieglstein C.F., Issekutz A.C., Granger D.N., Platelets modulate ischemia reperfusion-induced leukocyte recruitment in the mesenteric circulation, Am. J. Physiol., 281, (2001)

[4]

Bertuglia S., Giusti A., Fedele S., Picano E., Glucose-insulin-potassium treatment in combination with dipyridamole inhibits ischemia-reperfusion-induced damage, Diabetologia, 44, pp. 2165-2170, (2001)

[5]

Cook N.S., Kottirsch G., Zerwes H.G., Platelet glycoproteins IIb/IIIa antagonists, Drugs of the Future, 19, pp. 135-159, (1994)

[6]

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIa receptor in high-risk coronary angioplastly: The EPIC investigation, N. Engl. J. Med., 330, (1994)

[7]

Schulman S.P., Goldschmidt-Clennont P.J., Topol E.J., Effects of Integrilin a platelet glycoprotein IIb/IIa receptor antagonist in unstable angina, a multicenter trial, Circulation, 94, pp. 2083-2089, (1996)

[8]

Lele M., Stouffer G.A., Et al., Eptifibatide and 7E3, but not Tirofiban, inhibit α <sub>v</sub>β<sub>3</sub> Integrin-mediated binding of smooth muscle cells to thrombospondin and prothrombin, Circulation, 104, pp. 582-587, (2001)

[9]

Foster R.H., Wiseman L.R., Abciximab. An update review of its use in ischaemic heart disease, Drugs, 56, 4, pp. 629-665, (1998)

[10]

Rote W.E., Werns S.W., Davis J.H., Feigen L.P., Kilgore K.S., Lucchesi B.R., Platelet GPIIb/IIIa receptor inhibition by SC-49992 prevents thrombosis and rethrombosis in the canine carotid artery, Cardiovasc. Res., 27, pp. 500-507, (1993)

← 1 2 3 4 →